V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002403 | 10001579 | 0 | 78.8 | Palliative (P) | 2018-04-04 | 2018-04-17 | Enzalutamide | N | N | 10433629 | ENZALUTAMIDE |
| 10002404 | 10001580 | 1.54 | 53.9 | Palliative (P) | 2017-03-03 | 2017-03-19 | EOX | 02 | N | 10433645 | EOX |
| 10002405 | 10001581 | 1.72 | 68.2 | null | 2017-11-20 | 2017-11-20 | Hydroxycarbamide | 02 | N | 10433663 | HYDROXYCARBAMIDE |
| 10002406 | 10001582 | 1.8 | 60.4 | Palliative (P) | 2017-10-12 | 2017-10-26 | GEMCITABINE | null | null | 10433672 | GEMCITABINE |
| 10002407 | 10001583 | 1.78 | 83 | Palliative (P) | 2015-03-08 | 2015-03-15 | Rituximab | 02 | N | 10433688 | RITUXIMAB |
| 10002408 | 10001584 | null | 71.8 | Palliative (P) | 2017-06-11 | 2017-07-02 | GEMCITABINE | 02 | null | 10433721 | GEMCITABINE |
| 10002409 | 10001584 | 1.65 | 60 | Palliative (P) | 2018-09-07 | 2018-09-11 | Cisplatin + Pemetrexed | N | N | 10433721 | CISPLATIN + PEMETREXED |
| 10002410 | 10001585 | 1.78 | 59 | Palliative (P) | 2018-01-15 | 2018-01-15 | R GCVP | 02 | null | 10433746 | CVP R |
| 10002411 | 10001585 | 1.74 | 95.6 | Disease modification (D) | 2018-04-22 | 2018-04-22 | Trial Unspecified | Y | null | 10433746 | TRIAL |
| 10002412 | 10001585 | 1.7 | 91 | Neo-adjuvant (N) | 2018-12-01 | 2018-12-07 | ECX | N | N | 10433746 | ECX |
| 10002413 | 10001586 | 1.67 | 92.2 | Palliative (P) | 2018-09-04 | 2018-09-04 | CVP R | 2 | N | 10434009 | CVP R |
| 10002414 | 10001587 | 1.53 | 97.2 | Palliative (P) | 2016-07-04 | 2016-07-19 | Carboplatin + Vinorelbine Oral | 2 | N | 10434062 | CARBOPLATIN + VINORELBINE |
| 10002415 | 10001588 | 1.77 | 65 | Neo-adjuvant (N) | 2015-04-24 | 2015-05-24 | ECX | 2 | N | 10434086 | ECX |
| 10002416 | 10001588 | 1.56 | 69.2 | Palliative (P) | 2018-11-24 | 2018-11-25 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10434086 | GEMCITABINE |
| 10002417 | 10001588 | 1.64 | 98.4 | Disease modification (D) | 2014-09-07 | 2014-09-14 | PEMBROLIZUMAB | N | N | 10434086 | PEMBROLIZUMAB |
| 10002418 | 10001589 | 0 | 0 | Neo-adjuvant (N) | 2015-09-14 | 2015-09-25 | ECX | N | N | 10434178 | ECX |
| 10002419 | 10001590 | 1.72 | 65.6 | Palliative (P) | 2014-06-01 | 2014-06-04 | GEMCITABINE | N | N | 10434214 | GEMCITABINE |
| 10002420 | 10001591 | 0 | 51.4 | null | 2018-03-09 | 2018-03-13 | CVP R | N | N | 10434226 | CVP R |
| 10002421 | 10001591 | 1.69 | 77 | Disease modification (D) | 2014-05-29 | 2014-11-15 | Rituximab | 02 | N | 10434226 | RITUXIMAB |
| 10002422 | 10001592 | 1.72 | 84.2 | Adjuvant (A) | 2018-07-11 | 2018-07-23 | Cisplatin + Vinorelbine (PO) | N | N | 10434272 | CISPLATIN + VINORELBINE |
| 10002423 | 10001593 | 1.79 | 83.7 | Adjuvant (A) | 2018-02-07 | 2018-02-08 | Hydroxycarbamide | N | N | 10434320 | HYDROXYCARBAMIDE |
| 10002424 | 10001594 | 1.77 | 66 | Palliative (P) | 2014-03-31 | 2014-04-14 | CARBOPLATIN + VINORELBINE | 02 | N | 10434333 | CARBOPLATIN + VINORELBINE |
| 10002425 | 10001595 | 1.72 | null | Disease modification (D) | 2016-08-09 | 2016-08-10 | Hydroxycarbamide | N | N | 10434336 | HYDROXYCARBAMIDE |
| 10002426 | 10001595 | 1.55 | 54.6 | Adjuvant (A) | 2018-01-27 | 2018-02-18 | ECX | N | N | 10434336 | ECX |
| 10002427 | 10001595 | 1.72 | 80.8 | Palliative (P) | 2015-11-02 | 2015-11-02 | PEMBROLIZUMAB | 2 | N | 10434336 | PEMBROLIZUMAB |
| 10002428 | 10001595 | 1.67 | 45.1 | Palliative (P) | 2015-05-29 | 2015-05-29 | PEMBROLIZUMAB | 2 | N | 10434336 | PEMBROLIZUMAB |
| 10002429 | 10001595 | 1.69 | 73 | Palliative (P) | 2018-03-13 | 2018-03-14 | Enzalutamide | N | N | 10434336 | ENZALUTAMIDE |
| 10002430 | 10009213 | null | 75.7 | Palliative (P) | 2014-10-21 | 2014-10-21 | Carboplatin + Vinorelbine IV | 02 | N | 10434441 | CARBOPLATIN + VINORELBINE |
| 10002431 | 10001596 | 1.7 | 63.9 | Palliative (P) | 2015-01-10 | 2015-01-10 | Trial Unspecified | 01 | N | 10434445 | TRIAL |
| 10002432 | 10001597 | 1.7 | 62 | Palliative (P) | 2017-07-03 | 2017-07-07 | Cisplatin + Pemetrexed | 02 | N | 10434448 | CISPLATIN + PEMETREXED |
| 10002433 | 10001598 | 0 | 83.2 | null | 2015-01-22 | 2015-02-05 | CVP R | N | N | 10434515 | CVP R |
| 10002434 | 10001599 | 1.7 | 69 | Palliative (P) | 2017-03-12 | 2017-03-15 | GEMCITABINE | 02 | N | 10434542 | GEMCITABINE |
| 10002435 | 10006194 | 1.69 | 61 | Palliative (P) | 2016-05-23 | 2016-05-23 | Enzalutamide | null | N | 10434572 | ENZALUTAMIDE |
| 10002436 | 10001600 | null | 49.5 | Palliative (P) | 2018-09-14 | 2018-09-21 | Rituximab | 2 | N | 10434668 | RITUXIMAB |
| 10002437 | 10006195 | 1.61 | 66.2 | Palliative (P) | 2015-12-29 | 2016-01-26 | Cisplatin + Pemetrexed | 02 | N | 10434687 | CISPLATIN + PEMETREXED |
| 10002438 | 10001601 | null | 68.2 | null | 2018-05-11 | 2018-05-11 | CISPLATIN + VINORELBINE | 2 | N | 10434689 | CISPLATIN + VINORELBINE |
| 10002439 | 10001602 | 1.76 | 71 | Neo-adjuvant (N) | 2016-08-30 | 2016-09-04 | ECX | N | N | 10434734 | ECX |
| 10002440 | 10001603 | 1.7 | 82.5 | Palliative (P) | 2014-02-22 | 2014-03-07 | ECX | 2 | N | 10434761 | ECX |
| 10002441 | 10001604 | 1.65 | 89.5 | Adjuvant (A) | 2018-02-03 | 2018-02-22 | Cisplatin + Pemetrexed | 02 | N | 10434804 | CISPLATIN + PEMETREXED |
| 10002442 | 10001605 | 1.76 | 76.3 | Disease modification (D) | 2018-08-05 | 2018-08-07 | Rituximab | 2 | N | 10434839 | RITUXIMAB |
| 10002443 | 10001606 | 1.61 | 54.7 | Palliative (P) | 2017-09-19 | 2017-09-23 | CVP R | N | N | 10434879 | CVP R |
| 10002444 | 10001606 | 1.7 | 89 | Adjuvant (A) | 2014-07-18 | 2014-07-18 | Hydroxycarbamide | 02 | N | 10434879 | HYDROXYCARBAMIDE |
| 10002445 | 10001606 | 1.86 | 82.3 | Palliative (P) | 2014-02-01 | 2014-02-02 | PEMBROLIZUMAB | 2 | N | 10434879 | PEMBROLIZUMAB |
| 10002446 | 10001607 | 1.57 | 46.3 | Curative (C) | 2017-07-30 | 2017-09-14 | Cisplatin + Pemetrexed | N | N | 10434990 | CISPLATIN + PEMETREXED |
| 10002447 | 10001608 | 1.56 | null | Curative (C) | 2017-11-25 | 2017-12-01 | R GCVP | N | N | 10435046 | CVP R |
| 10002448 | 10001609 | 1.59 | 77 | Adjuvant (A) | null | 2013-12-08 | Cisplatin + Vinorelbine (PO) | N | N | 10435062 | CISPLATIN + VINORELBINE |
| 10002449 | 10001610 | 1.75 | 75 | Adjuvant (A) | 2015-10-12 | 2015-10-12 | Rituximab | 02 | N | 10435154 | RITUXIMAB |
| 10002450 | 10001611 | null | null | Palliative (P) | 2017-12-28 | 2017-12-28 | PEMBROLIZUMAB | N | N | 10435155 | PEMBROLIZUMAB |
| 10002451 | 10001611 | 1.59 | 75.6 | Palliative (P) | null | 2016-10-23 | GEMCITABINE | N | N | 10435155 | GEMCITABINE |
| 10002452 | 10001611 | 1.7 | 106.7 | Palliative (P) | 2016-03-09 | 2016-03-10 | EOX | 2 | N | 10435155 | EOX |